Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus a peek at the company’s roadmap for the future. Chris highlights:
- Varian’s new Bravos afterloader system for high-dose-rate (HDR) brachytherapy;
- Varian’s new ProBeam 360 single-room proton therapy system, with its lower-cost, 30 percent smaller footprint;
- The company’s vision of — and development work towards — an artificial intelligence-powered multimodality adaptive radiotherapy suite; and
- Pre-clinical research into ultra-high-dose-rate cancer treatment with protons.
For more information, visit: Varian
Varian's Oncology Systems business is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Read more related topics: